BRANCACCIO, DIEGO
BRANCACCIO, DIEGO
DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA (attivo dal 01/01/1999 al 26/04/2012)
Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis
2020 L. Muzio, R. Sirtori, D. Gornati, S. Eleuteri, A. Fossaghi, D. Brancaccio, L. Manzoni, L. Ottoboni, L.D. Feo, A. Quattrini, E. Mastrangelo, L. Sorrentino, E. Scalone, G. Comi, L. Marinelli, N. Riva, M. Milani, P. Seneci, G. Martino
BAD transmission and SAD distribution: a new scenario for critical limb ischemia
2018 R. Ferraresi, G. Mauri, F. Losurdo, N. Troisi, D. Brancaccio, C. Caravaggi, L. Neri
Chelanti del fosforo a base di ferro : quali nuovi vantaggi? = Iron-based Phosphate Binders for ESRD Patients
2016 M. Cozzolino, M. Mangano, L. Magagnoli, L. Di Lullo, A. Galassi, D. Brancaccio, A. Bellasi
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study
2016 D.P. Roggeri, A. Roggeri, D. Brancaccio, S. Mazzaferro, P. Messa, E. Paoletti, A. Possidoni, A.M. Costanzo, U. di Luzio Paparatti, M. Cozzolino
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study
2015 A. Roggeri, D.P. Roggeri, M. Cozzolino, S. Mazzaferro, D. Brancaccio, E. Paoletti, A.M. Costanzo, U. di Luzio Paparatti, V. Festa, P. Messa
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study
2015 P. Messa, M. Cozzolino, D. Brancaccio, G. Cannella, F. Malberti, A.M. Costanzo, U. di Luzio Paparatti, V. Festa, G. Gualberti, S. Mazzaferro
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex : Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis
2015 G. Pacini, A. Carotenuto, C. Rentier, F. Nuti, F. Real-Fernandez, D. Brancaccio, G. Sabatino, M. Larregola, E. Peroni, P. Migliorini, E. Novellino, P.M. Battezzati, C. Selmi, A.M. Papini, P. Rovero
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients : results of the FARO-2 Cohort
2014 M. Cozzolino, P. Messa, D. Brancaccio, G. Cannella, P. Bolasco, M. Di Luca, A.M. Costanzo, U. di Luzio Paparatti, V. Festa, G. Gualberti, S. Mazzaferro
Inequalities in transplant waiting list activation across Italian dialysis centers
2013 L. Neri, M. Gallieni, L.A. Rocca Rey, S.V. Bertoli, V. Andreucci, D. Brancaccio
Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease : a hypothesis
2013 M. Cozzolino, G. Gentile, S. Mazzaferro, D. Brancaccio, P. Ruggenenti, G. Remuzzi
The Calcimimetic Calindol Prevents High Phosphate-Induced Vascular Calcification by Upregulating Matrix GLA Protein
2013 P. Ciceri, F. Elli, I. Brenna, E. Volpi, D. Brancaccio, M. Cozzolino
Lanthanum Prevents High Phosphate-Induced Vascular Calcification by Preserving Vascular Smooth Muscle Lineage Markers
2013 P. Ciceri, F. Elli, I. Brenna, E. Volpi, S. Romagnoli, D. Tosi, P. Braidotti, D. Brancaccio, M. Cozzolino
The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification
2012 P. Ciceri, E. Volpi, I. Brenna, F. Elli, E. Borghi, D. Brancaccio, M.G. Cozzolino
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey
2012 M. Cozzolino, D. Brancaccio, G. Cannella, P. Messa, L. Gesualdo, M. Marangella, C. Lodeserto, M. Pozzato, G. Rombolà, A. Costanzo, U. di Luzio Paparatti, S. Mazzaferro
Encephalopathy in a dialysis patient treated with lanthanum carbonate (LC)
2012 D. Brancaccio, E. Rivolta, M. Cozzolino
Pharmacological control of secondary hyperparathyroidism in hemodialysis subjects: a cost consequences analysis of data from the FARO study
2012 D. Roggeri, S. Mazzaferro, D. Brancaccio, G. Cannella, P. Messa, M. Di Luca, M. Morosetti, A. Costanzo, U. Paparatti, D. Cornago, M. Cozzolino
Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation
2012 P. Ciceri, E. Volpi, I. Brenna, L. Arnaboldi, L. Neri, D. Brancaccio, M. Cozzolino
Clinical significance of FGF-23 measurement in dialysis patients
2011 F. Jongbloed, A. Galassi, M. Cozzolino, R. Zietse, G. Chiarelli, D. Cusi, D. Brancaccio, M. Gallieni
Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey
2011 S. Mazzaferro, D. Brancaccio, P. Messa, V. Andreucci, G. Bellinghieri, R. Bigazzi, P. Bolasco, A. Costanzo, U. di Luzio Paparatti, G. Cannella
CKD-MBD : an endless story
2011 D. Brancaccio, M.G. Cozzolino